Literature DB >> 1824810

Implications of peritoneal cytology for staging of early pancreatic cancer.

A L Warshaw1.   

Abstract

Cytologic examination of peritoneal washings was performed in 40 patients with pancreatic ductal adenocarcinoma (35 head, 5 body) whose tumors had been selected as potentially resectable by computed tomographic (CT) findings. Saline (100 mL) was instilled and aspirated at laparoscopy in 27 patients and at laparotomy in 13. Malignant cells were found in the peritoneal washings in 12 of 40 patients (30%): 29% in cancers of the pancreatic head versus 40% in the body; 33% at laparoscopy versus 23% at laparotomy; and in 4 of 8 patients with ascites versus 8 of 32 without ascites. The cytology was positive in 6 of 8 patients (75%) who had a prior percutaneous needle biopsy versus 6 of 32 (19%) of those who did not (p less than 0.01). Liver metastases were found in six patients, all with negative cytology. One of 10 pancreatic head cancers with positive cytology was resectable versus 13 of 25 with negative cytology (p less than 0.05). Survival was significantly longer in patients with negative cytology. We conclude that (1) pancreatic cancer sheds malignant cells into the peritoneum early and commonly; (2) laparoscopic lavage is an effective means of cytologic study; (3) ascites is not a precondition for cytologic study, nor does its presence necessarily imply carcinomatosis; (4) intraperitoneal spread of cancer cells may be promoted by tumor biopsy; (5) cytologic findings provide an additional index of resectability; and (6) cytologic findings appear to correlate with duration of survival. This study shows that even "localized" pancreatic cancer is often not contained and suggests caution with biopsy of potentially curable lesions.

Entities:  

Mesh:

Year:  1991        PMID: 1824810     DOI: 10.1016/0002-9610(91)90356-i

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  53 in total

Review 1.  Recent advances in the surgical treatment of pancreatic cancer.

Authors:  A Shankar; R C Russell
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

Review 2.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

3.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

4.  Implications of malignant-cell DNA content for treatment of patients with pancreatic cancer.

Authors:  A L Warshaw
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

5.  A prospective evaluation of cytology from biliary strictures.

Authors:  J C Mansfield; S M Griffin; V Wadehra; K Matthewson
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

6.  Tuberculosis of the pancreas.

Authors:  S Varshney; C D Johnson
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

7.  Role of fine needle aspiration cytology and endoscopic biopsy in the preoperative assessment of pancreatic and peripancreatic malignancies.

Authors:  R Nakamura; R Machado; K Amikura; B Ruebner; C F Frey
Journal:  Int J Pancreatol       Date:  1994-08

8.  Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?

Authors:  Osamu Ishikawa; Hiroshi Wada; Hiroaki Ohigashi; Yuichiro Doki; Shigekazu Yokoyama; Shingo Noura; Terumasa Yamada; Yo Sasaki; Shingi Imaoka; Tsutomu Kasugai; Takashi Matsunaga; Akemi Takenaka; Akihiko Nakaizumi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

Review 9.  Staging gastrointestinal cancer as a precondition for multimodal treatment.

Authors:  J R Siewert; A Sendler; H J Dittler; U Fink; H Höfler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

10.  Reliability of pancreatic cancer staging classifications.

Authors:  A Zerbi; G Balzano; R Bottura; V Di Carlo
Journal:  Int J Pancreatol       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.